[Federal Register Volume 83, Number 191 (Tuesday, October 2, 2018)]
[Notices]
[Pages 49579-49580]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21354]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Registrants listed below have applied for and been granted 
registration by the Drug Enforcement Administration (DEA) as importers 
of various classes of schedule I or II controlled substances.

[[Page 49580]]


SUPPLEMENTARY INFORMATION: The companies listed below applied to be 
registered as importers of various basic classes of controlled 
substances. Information on previously published notices are listed in 
the table below. No comments or objections were submitted and no 
requests for hearing were submitted for these notices.

------------------------------------------------------------------------
            Company                 FR Docket            Published
------------------------------------------------------------------------
AMRI Rensselaer, Inc..........  83 FR 15176        April 9, 2018.
S&B Pharma, Inc...............  83 FR 31421        July 5, 2018.
Cerilliant Corporation........  83 FR 32906        July 16, 2018.
Shertech Laboratories, LLC....  83 FR 34879        July 23, 2018.
Fresenius Kabi USA, LLC.......  83 FR 34878        July 23, 2018.
VHG Labs DBA LGC Standards....  83 FR 34875        July 23, 2018.
Catalent Pharma Solutions, LLC  83 FR 34874        July 23, 2018.
Fisher Clinical Services, Inc.  83 FR 34879        July 23, 2018.
Anderson Brecon, Inc..........  83 FR 37525        August 1, 2018.
------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of the listed registrants 
to import the applicable basic classes of schedule I or II controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971.
    The DEA investigated each company's maintenance of effective 
controls against diversion by inspecting and testing each company's 
physical security systems, verifying each company's compliance with 
state and local laws, and reviewing each company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer for schedule I or II controlled substances to the above 
listed companies.

    Dated: September 20, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-21354 Filed 10-1-18; 8:45 am]
 BILLING CODE 4410-09-P